Post-operative Hemorrhage

2

Review clinical trials related to Post-operative Hemorrhage. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Ultrasound for Assessment of Intra-Abdominal Blood Loss After Gynecological Surgery

This is a prospective cohort study designed to assess intra-abdominal blood volume and hemodynamic status by measuring the diameter of the inferior vena cava (IVC) using 3D and Doppler ultrasound within 24 hours after gynecological surgery. The study will examine the association between these ultrasound findings and postoperative outcomes, including hemoglobin drop, need for blood transfusion, pain, infection, and length of hospitalization. Approximately 250 women undergoing laparotomy, laparoscopy, or vaginal surgery at Holy Family Hospital will be enrolled. The study also aimed to define postoperative normograms for fluid volume and IVC parameters and to evaluate whether ultrasound-guided decision-making could improve postoperative care and reduce unnecessary interventions.

Participants needed: 250
Trial details
Age: 18-70Biological sex: FemaleType: ObservationalSponsor: Holy Family Hospital, Nazareth, IsraelUpdated: Apr 13, 2026Locations: 1Duration: 4 Days
Eligibility criteria

Women aged 18 years and older [+2]

Undergoing minor procedures (e.g., dilation and curettage, hysteroscopy, or cerv... [+3]

Status: Not yet recruiting

TEG Use in Children Undergoing Procedures With High Anticipated Blood Loss

The research team proposes a prospective, observational study to better understand how TEG can be useful in guiding clinical practice in the Main OR for subject's undergoing high transfusion risk surgeries. Intraoperatively, transfusion of blood products is frequently required to restore oxygen carrying capacity, perfusion and improve coagulation. Both under and over transfusion pose significant risks, particularly to pediatric patients with small starting intravascular volumes. Thromboelastography (TEG) is a validated method of dynamically assessing intraoperative coagulopathy via functional assay. However, while FDA approved and widely used in the adult setting, TEG is not commonly utilized in the setting of bleeding pediatric patients. Recently, TEG has been made available at BCH for clinical purposes and is being used solely in the cardiac surgery setting. The investigators aim to provide TEG data for non-cardiac pediatric surgical cases with a high risk of intraoperative blood loss in order to assess the impact of this tool on intraoperative management.

Participants needed: 60
Trial details
Age: Up to 20Biological sex: AllType: InterventionalSponsor: Boston Children's HospitalUpdated: Aug 20, 2024
Eligibility criteria

Pediatric patients undergoing non-cardiac surgery at BCH with a high likelihood... [+9]

Patients undergoing cardiac surgery or ECMO cannulation, as these surgeries are... [+2]